Addictions

Overview of Addiction

  • Definition Complexity

    • Different definitions exist; addiction is a term with varied meanings based on context.

    • Core components of addiction:

    1. Engagement: The activity or substance is something one enjoys doing.

    2. Compulsion: An inability to stop the behavior despite wanting to.

    3. Consequences: The behavior or substance use leads to negative outcomes in life.

  • Brain Disease Theory:

    • Proposes that habitual use of substances or compulsive behaviors leads to changes in brain function and structure.

    • Emphasizes the alterations in neural circuitry related to addiction.

Behavioral Addiction

  • Inclusion in DSM:

    • Behavioral addictions, such as gambling, were first recognized in DSM-5.

    • Importance of understanding neural pathways in both substance and behavioral addictions.

Neurological Mechanisms

  • Dopamine and Reward Pathways:

    • Pleasure derived from activities/substances is linked to increased dopamine in the nucleus accumbens.

    • Common neural circuitry is shared across both substance and behavioral addictions.

Diagnostic Criteria for Substance Use Disorders

  • Types of Use Disorders:

    • Various specific substance use disorders exist (e.g., opioid use disorder, alcohol use disorder).

    • Diagnostic criteria derived from DSM focus on impaired control among first four criteria.

  • Lifetime Prevalence:

    • Refers to the likelihood of an individual meeting diagnostic criteria for an addiction at some point.

Co-occurring Mental Health Disorders

  • Dual Diagnosis Concept:

    • High rates of co-occurrence between substance use disorder and mental health conditions, often referred to as dual diagnosis.

    • Statistics: Only about 10% of individuals receive treatment for both conditions; about 35% are treated solely for mental health conditions.

  • Self-Medication Hypothesis:

    • Common belief: people use substances to alleviate mental health symptoms.

    • Evidence suggests this is not accurate, as data indicates:

    • People with depression do not necessarily choose substances that help them feel better.

    • Withdrawal and symptoms often persist regardless of mental health fluctuations.

Genetic and Environmental Factors

  • Genetic Vulnerabilities:

    • Genetic predispositions can influence the likelihood of developing mental health issues post-substance use.

    • Substance use can trigger genetic predispositions, exacerbating mental health symptoms.

  • Common Neurocognitive Issues:

    • Problems with self-regulation noted in both substance use disorders and certain mental health conditions.

    • Early exposure to adverse life experiences may influence susceptibility to both issues as one develops.

Treatment Paradigms

  • Historical Treatment Approaches:

    • Traditionally, substance use disorders are treated first, with the hope of addressing remaining mental health symptoms afterward.

    • Current paradigms advocate treating both issues simultaneously to manage overall functioning and impairment.

  • Integrated Treatment:

    • Combined approaches to address substance use and mental health concurrently.

    • Significance in addressing depressive symptoms alongside substance withdrawal during detox.

Medications for Substance Use Disorders

  • Common Medications:

    • Disulfiram (Antabuse): causes nausea/vomiting when combined with alcohol.

    • Naltrexone: helps curb cravings; also used for binge eating disorders, blocking euphoric effects from opioids.

    • Wellbutrin (Bupropion): a dopamine and norepinephrine reuptake inhibitor (DNRI) used for smoking cessation and also binge eating.

  • Benzodiazepines:

    • Used to manage withdrawal symptoms from alcohol, given their chemical similarities to alcohol.

    • Tapering process typically begins with a higher dose and gradually reduces over time.

  • CAPRO (Gabapentinoids):

    • Regulates glutamate to alleviate withdrawal; may be effective in reducing negative withdrawal symptoms when combined with naltrexone.

Opioid Use Disorder

  • Overview of Opioids:

    • Opioids, both naturally occurring and synthetic, bind to opioid receptors and modulate pain, euphoria, and sedation.

  • Withdrawal Management:

    • Naloxone: rapid opioid receptor blocker to use in cases of overdose.

    • Methadone: a synthetic opioid used for maintenance treatments that helps manage withdrawal symptoms without euphoric effects.

Implications of Treatment Approaches

  • Treatment Challenges:

    • Recovery often involves the challenge of balancing treatment logistics (e.g., strict clinic hours for methadone therapy) and personal life.

    • Tough reality of relapse upon discontinuation of maintenance treatments like methadone, with high rates of return to substance use.

  • Ethical Considerations:

    • Debate exists over the treatment of clients solely for substance use before addressing their underlying mental health conditions.

    • Importance of recognizing and treating co-occurring conditions effectively to promote overall recovery.